Search results
Zentalis Pharmaceuticals (NASDAQ:ZNTL) PT Lowered to $20.00 at HC Wainwright
ETF DAILY NEWS· 5 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective cut by HC Wainwright from $40.00 to $20.00 in a report issued on Tuesday morning, Benzinga reports. Stifel Nicolaus ...
Wegovy, Zepbound: Weight Loss Drugs May Help You Live a Longer Life
Healthline· 6 days agoDoctors are beginning to examine other benefits of this class of drugs, which may help you to live...
Oppenheimer Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $25.00
ETF DAILY NEWS· 5 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective trimmed by Oppenheimer from $50.00 to $25.00 in a report issued on Tuesday morning, Benzinga reports. Wells Fargo ...
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor,...
Tehachapi News· 5 days agoG12D mutation is the most prevalent KRAS mutation detected in human cancers, and no G12D-targeted therapies have been approved yet.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by Wedbush
ETF DAILY NEWS· 5 days agoWedbush downgraded shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday morning, MarketBeat ...
After 35 years, coach Joe Hohman continues to make an impact at Divine Mercy Academy
Pittsburgh Tribune-Review· 20 hours agoJoe Hohman may not be the biggest name in area basketball coaching circles, but the long-tenured...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target Cut to $10.00 by Analysts at Stifel Nicolaus
ETF DAILY NEWS· 5 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective reduced by Stifel Nicolaus from $32.00 to $10.00 in a research report report published on Tuesday morning, Benzinga ...
RenovoRx (NASDAQ:RNXT) Receives New Coverage from Analysts at Ascendiant Capital Markets
ETF DAILY NEWS· 6 days agoAscendiant Capital Markets assumed coverage on shares of RenovoRx (NASDAQ:RNXT – Free Report) in a report issued on Monday morning, Benzinga reports. The firm issued a buy rating and a $8.00 ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by UBS Group
ETF DAILY NEWS· 4 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) was downgraded by UBS Group from a “buy” rating to a “neutral” rating in a report issued on Thursday, Briefing.com reports. UBS Group ...
Wells Fargo & Company Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Equal Weight
ETF DAILY NEWS· 5 days agoWells Fargo & Company downgraded shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an overweight rating to an equal weight rating in a research report report published on Tuesday ...